Literature DB >> 4382352

[On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics].

R Degkwitz, K F Binsack, H Herkert, O Luxenburger, W Wenzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4382352

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  10 in total

1.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; R Teuflmayr
Journal:  Dtsch Z Nervenheilkd       Date:  1969

2.  Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs.

Authors:  W C Koller
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.

Authors:  K J Dewey; H C Fibiger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

4.  Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis.

Authors:  Lasse Brandt; Tom Bschor; Jonathan Henssler; Martin Müller; Alkomiet Hasan; Andreas Heinz; Stefan Gutwinski
Journal:  Front Psychiatry       Date:  2020-09-29       Impact factor: 4.157

5.  [Deanol in tardive dyskinesia: a double-blind study (author's transl)].

Authors:  S Bockenheimer; G Lucius
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-09-17

6.  Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.

Authors: 
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.

Authors:  H Morgenstern; W M Glazer; D Niedzwiecki; P Nourjah
Journal:  Am J Public Health       Date:  1987-06       Impact factor: 9.308

8.  Release phenomena and iterative activities in psychiatric geriatric patients.

Authors:  A Villeneuve; J Turcotte; M Bouchard; J M Côté; A Jus
Journal:  Can Med Assoc J       Date:  1974-01-19       Impact factor: 8.262

9.  Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.

Authors:  J S Smith; L G Kiloh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

10.  Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly.

Authors:  J M Kane; P Weinhold; B Kinon; J Wegner; M Leader
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.